Disappointing economic data weighed the markets down to a lower close with the Dow slipping 23 points to 17,755. Nasdaq dropped 21 points to 5,074.
On the upside
Third quarter earnings for Iridium Communications (Nasdaq: IRDM) climbed to beat analyst expectations.
Quidel (Nasdaq: QDEL) narrowed losses for the third quarter as revenue rose.
HanesBrands (NYSE: HBI) reported higher third quarter earnings and revenue that surpassed estimates prompting the basic apparel company to lift its full year earnings outlook.
On the downside
Applied DNA Sciences (Nasdaq: APDN) responded to an anonymous opinion piece suggesting that investors short Applied DNA Sciences.
A Food and Drug Administration’s advisory committee cancelled its meeting to review Repros Therapeutics’ (Nasdaq: RPRX) New Drug Application for enclomiphene.
MiMedx Group (Nasdaq: MDXG) reported higher third quarter earnings and revenue but investors were disappointed that the results merely met expectations.
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 eased a fraction to 2,089. Bitcoin slipped $1 to $308.
